Blum Holdings (Blum Holdings) GF Value Rank : 2 (As of May. 06, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings GF Value Rank?

Blum Holdings has the GF Value Rank of 2.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Blum Holdings's GF Value Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Blum Holdings's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blum Holdings's GF Value Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blum Holdings's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Blum Holdings's GF Value Rank falls into.

Blum Holdings GF Value Rank Related Terms

Thank you for viewing the detailed overview of Blum Holdings's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Blum Holdings (Blum Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blum Holdings Inc (OTCPK:BLMH) » Definitions » GF Value Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

3242 South Halladay Street, Suite 202, Santa Ana, CA, USA, 92705

Website

https://www.unrivaledbrands.com

Blum Holdings Inc formerly Unrivaled Brands Inc is a vertically integrated cannabis multi-state operator having a cannabis brand spanning consumer products, cultivation, distribution, and retail. Its brands include Korova, Sticks, and Cabana, among others. It operates leading dispensaries throughout the state as well as several leading company-owned brands including Korova, known for its high potency products across multiple product categories.

Executives

Patty Chan	officer: CHIEF FINANCIAL OFFICER	11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble	officer: President	3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo	director	1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum	director	866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis	director	11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass	director	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson	director, officer: President and CEO	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone	other: Former Director of Issuer	P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig	officer: Chief Operating Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter	director	C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich	director	2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis	director	205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner	officer: Chief Financial Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez	officer: Chief Financial Officer	2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan	director, officer: Chief Executive Officer	2040 MAIN STREET, SUITE 225, IRVINE CA 92614